Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Jan;19(1):87–93. doi: 10.1128/iai.19.1.87-93.1978

Induction of cell-mediated immunity to Mycobacterium leprae in mice.

P J Patel, M J Lefford
PMCID: PMC414052  PMID: 415009

Abstract

The immune response of mice to armadillo-derived, irradiation-killed Mycobacterium leprae (I-ML) was investigated. Following injection of 100 microgram of I-ML into the left hind footpads of mice, a state of cell-mediated immunity (CMI) was engendered to antigens of M. leprae. The evidence for CMI was as follows: (i) development of delayed-type hypersensitivity to both human tuberculin purified protein derivative and soluble M. leprae antigens; (ii) T-lymphocyte-dependent macrophage activation at the inoculation site; (iii) specific systemic resistance to the cross-reactive species M. tuberculosis; and (iv) immunopotentiation of the delayed-type hypersensitivity response to an unrelated antigen. The CMI induced by I-ML in aqueous suspension was greater than that obtained with the same antigen in water-in-oil emulsion, even though the latter generated a more severe reaction at the site of immunization. I-ML also induced a stronger CMI response than the corresponding dose of heat-killed BCG.

Full text

PDF
88

Images in this article

89Image
on p.89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanden R. V., Lefford M. J., Mackaness G. B. The host response to Calmette-Guérin bacillus infection in mice. J Exp Med. 1969 May 1;129(5):1079–1107. doi: 10.1084/jem.129.5.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Closs O., Haugen O. A. Experimental murine leprosy. 3. Early local reaction to mycobacterium lepraemurium in C3H and C57/BL mice. Acta Pathol Microbiol Scand A. 1975 Jan;83(1):51–58. [PubMed] [Google Scholar]
  3. Fieldsteel A. H., Levy L. Neonatally thymectomized Lewis rats infected with Mycobacterium leprae: response to primary infection, secondary challenge, and large inocula. Infect Immun. 1976 Sep;14(3):736–741. doi: 10.1128/iai.14.3.736-741.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Granger D. L., Brehmer W., Brehmer W., Yamamoto K., Ribi E. Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy. Infect Immun. 1976 Feb;13(2):543–553. doi: 10.1128/iai.13.2.543-553.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kronvall G., Stanford J. L., Walsh G. P. Studies of mycobacterial antigens, with special reference to Mycobacterium leprae. Infect Immun. 1976 Apr;13(4):1132–1138. doi: 10.1128/iai.13.4.1132-1138.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lefford M. J. Transfer of adoptive immunity to tuberculosis in mice. Infect Immun. 1975 Jun;11(6):1174–1181. doi: 10.1128/iai.11.6.1174-1181.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mackaness G. B., Lagrange P. H., Ishibashi T. The modifying effect of BCG on the immunological induction of T cells. J Exp Med. 1974 Jun 1;139(6):1540–1552. doi: 10.1084/jem.139.6.1540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Miller T. E., Mackaness G. B., Lagrange P. H. Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst. 1973 Nov;51(5):1669–1676. doi: 10.1093/jnci/51.5.1669. [DOI] [PubMed] [Google Scholar]
  10. North R. J., Kirstein D. P. T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites. J Exp Med. 1977 Feb 1;145(2):275–292. doi: 10.1084/jem.145.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rees R. J. Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature. 1966 Aug 6;211(5049):657–658. doi: 10.1038/211657a0. [DOI] [PubMed] [Google Scholar]
  12. SHEPARD C. C. VACCINATION AGAINST EXPERIMENTAL INFECTION WITH MYCOBACTERIUM LEPRAE. Am J Epidemiol. 1965 Mar;81:150–163. doi: 10.1093/oxfordjournals.aje.a120504. [DOI] [PubMed] [Google Scholar]
  13. Shepard C. C. Vaccination of mice against M. leprae infection. Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):222–226. [PubMed] [Google Scholar]
  14. Spitalny G. L., North R. J. Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth. J Exp Med. 1977 May 1;145(5):1264–1277. doi: 10.1084/jem.145.5.1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stanford J. L. Immunodiffusion analysis--a rational basis for the taxonomy of mycobacteria. Ann Soc Belg Med Trop. 1973;53(4):321–330. [PubMed] [Google Scholar]
  16. Turk J. L., Bryceson A. D. Immunological phenomena in leprosy and related diseases. Adv Immunol. 1971;13:209–266. doi: 10.1016/s0065-2776(08)60185-6. [DOI] [PubMed] [Google Scholar]
  17. Youdim S., Stuntman O., Good R. A. Thymus dependency of cells involved in transfer of delayed hypersensitivity to Listeria monocytogenes in mice. Cell Immunol. 1973 Sep;8(3):395–402. doi: 10.1016/0008-8749(73)90129-9. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES